Pharmacological Strategies for Midventricular Obstruction in Patients with Hypertrophic Cardiomyopathy.
作者信息
Minami Yuichiro, Hagiwara Nobuhisa
机构信息
Department of Cardiology, Tokyo Women's Medical University, Japan.
出版信息
Intern Med. 2019 Feb 15;58(4):463-464. doi: 10.2169/internalmedicine.1668-18. Epub 2018 Oct 17.
Abstract
摘要
相似文献
1
Pharmacological Strategies for Midventricular Obstruction in Patients with Hypertrophic Cardiomyopathy.
Intern Med. 2019 Feb 15;58(4):463-464. doi: 10.2169/internalmedicine.1668-18. Epub 2018 Oct 17.
2
Bisoprolol Successfully Improved the Intraventricular Pressure Gradient in a Patient with Midventricular Obstructive Hypertrophic Cardiomyopathy with an Apex Aneurysm due to Apical Myocardial Damage.
Intern Med. 2019 Feb 15;58(4):535-539. doi: 10.2169/internalmedicine.0997-18. Epub 2018 Oct 17.
3
Hypertrophic cardiomyopathy with midventricular obstruction and apical aneurysm: a case report.
Jpn Circ J. 2001 Oct;65(10):915-9. doi: 10.1253/jcj.65.915.
4
[Apical hypertrophic cardiomyopathy followed by midventricular obstruction and apical aneurysm: a case report].
J Cardiol. 1999 Apr;33(4):217-22.
5
Apical hypertrophic cardiomyopathy with midventricular obstruction and apical aneurysm.
Int J Cardiol. 2007 Jan 8;114(2):E45-7. doi: 10.1016/j.ijcard.2006.07.208. Epub 2006 Oct 27.
6
[A case of apical hypertrophic cardiomyopathy developed into apical aneurysm with midventricular cavity obstruction].
Zhonghua Xin Xue Guan Bing Za Zhi. 2024 Jan 24;52(1):79-81. doi: 10.3760/cma.j.cn112148-20231009-00271.
7
Left ventricular aneurysms in hypertrophic cardiomyopathy with midventricular obstruction: A systematic review of literature.
Pacing Clin Electrophysiol. 2018 Jul;41(7):854-865. doi: 10.1111/pace.13380. Epub 2018 Jun 20.
8
Hypertrophic cardiomyopathy with massive midventricular hypertrophy, midventricular obstruction and an akinetic apical chamber.
Anadolu Kardiyol Derg. 2006 Sep;6(3):279-82.
9
Transapical approach for apical myectomy and relief of midventricular obstruction in hypertrophic cardiomyopathy.
J Card Surg. 2012 Jul;27(4):443-8. doi: 10.1111/j.1540-8191.2012.01475.x. Epub 2012 May 29.
10
Combined transaortic and transapical approach to septal myectomy in patients with complex hypertrophic cardiomyopathy.
J Thorac Cardiovasc Surg. 2018 May;155(5):2096-2102. doi: 10.1016/j.jtcvs.2017.10.054. Epub 2017 Oct 27.
引用本文的文献
1
Mid-Cavitary Obstruction in Hypertrophic Cardiomyopathy (HCM): A Rare Case Report and Management Approach.
Acta Med Litu. 2025;32(1):138-144. doi: 10.15388/Amed.2025.32.1.16. Epub 2025 Feb 18.
本文引用的文献
1
Bisoprolol Successfully Improved the Intraventricular Pressure Gradient in a Patient with Midventricular Obstructive Hypertrophic Cardiomyopathy with an Apex Aneurysm due to Apical Myocardial Damage.
Intern Med. 2019 Feb 15;58(4):535-539. doi: 10.2169/internalmedicine.0997-18. Epub 2018 Oct 17.
2
Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and Management.
J Am Coll Cardiol. 2017 Feb 21;69(7):761-773. doi: 10.1016/j.jacc.2016.11.063.
3
Implantable cardioverter defibrillator therapy and sudden death risk stratification in hypertrophic cardiomyopathy patients with midventricular obstruction: A single-center experience.
Int J Cardiol. 2016 Jul 1;214:419-22. doi: 10.1016/j.ijcard.2016.03.231. Epub 2016 Apr 4.
4
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).
Eur Heart J. 2014 Oct 14;35(39):2733-79. doi: 10.1093/eurheartj/ehu284. Epub 2014 Aug 29.
5
Phenotypic overlap in hypertrophic cardiomyopathy: apical hypertrophy, midventricular obstruction, and apical aneurysm.
J Cardiol. 2014 Dec;64(6):463-9. doi: 10.1016/j.jjcc.2014.03.003. Epub 2014 Apr 24.
6
Transapical approach to myectomy for midventricular obstruction in hypertrophic cardiomyopathy.
Ann Thorac Surg. 2013 Aug;96(2):564-70. doi: 10.1016/j.athoracsur.2013.04.073. Epub 2013 Jun 26.
7
Clinical characteristics and natural history of hypertrophic cardiomyopathy with midventricular obstruction.
Circ J. 2013;77(9):2366-74. doi: 10.1253/circj.cj-12-1561. Epub 2013 May 31.
8
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
J Am Coll Cardiol. 2011 Dec 13;58(25):e212-60. doi: 10.1016/j.jacc.2011.06.011. Epub 2011 Nov 8.
9
Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy.
J Am Coll Cardiol. 2011 Jun 7;57(23):2346-55. doi: 10.1016/j.jacc.2011.02.033.
10
Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.
Circulation. 2008 Oct 7;118(15):1541-9. doi: 10.1161/CIRCULATIONAHA.108.781401. Epub 2008 Sep 22.
Zotero 插件